ZYVERSA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ZYVERSA THERAPEUTICS, INC. (ZVSA) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 6.91 million shares as of 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-03-31
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 6.91M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 6.91M shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 3.85M shares.
- 2025-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 3.85M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2025-12-31 | 6.91M shares 10-K · filed 2026-03-31 | |
| 2025-09-30 | 6.91M shares 10-Q · filed 2025-11-19 | |
| 2025-06-30 | 3.85M shares 10-Q · filed 2025-08-13 | |
| 2025-03-31 | 3.85M shares 10-Q · filed 2025-05-12 | |
| 2024-12-31 | 1.75M shares 10-K · filed 2026-03-31 | |
| 2024-09-30 | 928.59K shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 689.29K shares 10-Q · filed 2024-08-09 | |
| 2024-03-31 | 689.52K shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 903.32K shares 10-K · filed 2025-03-27 | 9.03M shares 10-K · filed 2024-03-25 |
| 2023-09-30 | 36.38M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 23.74M shares 10-Q · filed 2023-08-21 | |
| 2022-12-31 | 246.59K shares 10-K · filed 2024-03-25 | 8.63M shares 10-Q · filed 2023-08-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |